Randomized phase II/III trial of gemcitabine plus nab-paclitaxel versus concurrent chemoradiotherapy with S-1 as neoadjuvant treatment for borderline resectable pancreatic cancer: GABARNANCE study.

Autor: Ikeda, Masafumi, Nomura, Shogo, Kobayashi, Tatsushi, Kimura, Yasutoshi, Morinaga, Soichiro, Toyama, Hirochika, Sugiura, Teiichi, Hirano, Satoshi, Shimizu, Yasuhiro, Tomikawa, Moriaki, Sadamori, Hiroshi, Katanuma, Akio, Horie, Yoshiki, Unno, Michiaki, Sugimachi, Keishi, Yamaguchi, Hironori, Kojima, Motohiro, Akimoto, Tetsuo, Uesaka, Katsuhiko, Takahashi, Shinichiro
Zdroj: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA4014-LBA4014, 83p
Databáze: Supplemental Index